Catalyst Wire Dossier Catalyst Wire Dossier

YHR2403

· Yuhan Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YHR2403, covering 2024-11-22 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis [Phase 3]

See pricing